This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—It has been called to our attention that the observations in our paper "Fatal Complications of Intensive Antibiotic Therapy in Patients with Neoplastic Disease," published in the A. M. A. Archives of Internal Medicine (90:763, 1952), might militate against the use of such a valuable antibiotic as oxytetracycline ("terramycin"). We sincerely trust that this will not be the case. We should like to emphasize the fact that we were dealing with severely ill patients who received doses of "terramycin" that were usually larger, more concentrated, and administered more rapidly than is recommended by the manufacturers of this drug. We now have some data which indicate that in patients of this type high blood and urine "terramycin" levels can be obtained after very small intravenous doses of this antibiotic. This route of administration avoids gastrointestinal complications, which may become serious in debilitated patients.We should like to reemphasize
Bateman JC. FATAL COMPLICATIONS OF INTENSIVE ANTIBIOTIC THERAPY IN PATIENTS WITH NEOPLASTIC DISEASE. AMA Arch Intern Med. 1953;91(4):556. doi:10.1001/archinte.1953.00240160142011
Best of JAMA Network 2022
Customize your JAMA Network experience by selecting one or more topics from the list below.